Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: jon wilson who wrote (701)	7/1/1998 4:06:00 PM
From: jake burns	Read Replies (1) \| Respond to of 1510

Technicals may be very useful, but they don't take into account substantive information that will be released tomorrow and friday.

To: jon wilson who wrote (701)	7/1/1998 4:12:00 PM
From: Jane4IceCream	Respond to of 1510

Technicals are not important with IMNR because you are investing on the "story" and the future.... Seems to be the case with most biotechs until they have positive earnings and products on the market... That is why IMNR has in the past and will again in the near future spike on news then give some back with nothing substantive like earnings to hold the stock up. Plus take into account those that will take their profits and run. Jane J Jackson of California

To: jon wilson who wrote (701)	7/1/1998 4:37:00 PM
From: Brian Thomas Hertzog	Respond to of 1510

Technical analysis is very important to ALL stocks. Technical analysis adds a third dimension to stock trading. Their are some positive signs from Dorsey Wright analysis. IMNR is trading in positive relative strength compared to the Dow and demonstrates a strong upward trend dating back to Feb '98. Their is a upward level of support at $13.50. A price drop to $12 would break the resistance and the upward trend line. Good luck to all those long and short. Their is enough room for both of us. --BHertzog